Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction

American Journal of Medicine

Volumn 115, Issue 6, 2003, Pages 473-479

  Rodrigues, Eric J ^a,c   Eisenberg, Mark J ^b,c   Pilote, Louise ^a,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PLACEBO; RAMIPRIL; TRANDOLAPRIL; ZOFENOPRIL;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRUG EFFECT; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0141892837     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00435-2     Document Type: Review

References (41)

1. Khalil M., Basher A., Brown E.J., Alhaddad I. A remarkable medical story benefits of angiotensin-converting enzyme inhibitors in cardiac patients . J Am Coll Cardiol. 37:2001;1757-1764.
2. Neaton J.D., Grimm R.H., Prineas R.J., et al. Treatment of Mild Hypertension Study. Final results. JAMA. 270:1993;713-724.
3. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 273:1995;1450-1456.
4. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 94:1996;258-265.
5. Ruggenenti P., Perna A., Remuzzi G. ACE inhibitors to prevent end-stage renal disease when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy . J Am Soc Nephrol. 12:2001;2832-2837.
6. Latini R., Maggioni A.P., Flather M., et al. ACE inhibitor use in patients with myocardial infarction summary of evidence from clinical trials . Circulation. 92:1995;3132-3137.
7. Indications for ACE inhibitors in the early treatment of acute MI systematic overview of individual data from 100,000 patients in randomized trials . Circulation. 97:1998;2202-2212.
8. Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction a systematic overview of data from individual patients . Lancet. 355:2000;1575-1581.
9. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction an overview of the randomized trials . Prog Cardiovasc Dis. 27:1985;335-371.
10. Pfeffer M.A., Greaves S.C., Arnold J.M.O., et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction the Healing and Early Afterload Reducing Therapy trial . Circulation. 95:1997;2643-2651.
11. ISIS-4 a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction . Lancet. 345:1995;669-685.
12. GISSI-3 effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction . Lancet. 343:1994;1115-1122.
13. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction interim report from the Chinese Cardiac Study (CCS-1) . Lancet. 345:1995;686-687.
14. Swedberg K., Held P., Kjekshus J., et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) . N Engl J Med. 327:1992;678-684.
15. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 332:1995;80-85.
16. French J.K., Amos D.J., Williams B.F., et al. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. J Am Coll Cardiol. 33:1999;139-145.
17. van Gilst W.H., Kingma J.H., Peels K.H., et al. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 28:1996;114-121.
18. Borghi C., Marino P., Zardini P., et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis results from the Fosinopril in Acute Myocardial Infarction Study . Am Heart J. 136:1998;213-225.
19. Foy S.G., Crozier I.G., Turner J.G., et al. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study). Am J Cardiol. 73:1994;1180-1186.
20. Kleber F.X., Sabin G.V., Winter U.J., et al. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction results of the German multicenter study of the Effects of Captopril on Cardiopulmonary Exercise parameters (ECCE) . Am J Cardiol. 80:1997;162A-167A.
21. Sharpe N., Smith H., Murphy J., et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 337:1991;872-876.
22. Ray S.G., Pye M., Oldroyd K.G., et al. Early treatment with captopril after acute myocardial infarction. Br Heart J. 69:1993;215-222.
23. Schulman S.P., Weiss J.L., Becker L.C., et al. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. Am J Cardiol. 76:1995;764-770.
24. Nabel E.G., Topol E.J., Galeana A., et al. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. J Am Coll Cardiol. 17:1991;467-473.
25. The HOPE (Heart Outcomes Prevention Evaluation) Study the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events . Can J Cardiol. 12:2000;127-137.
26. Pfeffer M., Braunwald E., Moye L., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 327:1992;669-677.
27. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
28. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
29. Effects of enalapril on left ventricular function and exercise performance after a first acute myocardial infarction. Int J Cardiol. 59:1997;257-265.
30. Pfeffer M.A., Lamas G., Vaughan D.E., Parisi A.F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
31. Sogaard P., Gotzsche C.O., Ravkilde J., Norgaard A., Thygesen K. Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction effect of intervention with captopril . Circulation. 90:1994;101-107.
32. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1:1988;255-259.
33. Mortarino G., Ghiringhelli M., Onofri M., Trudu A., Corda G. Mechanocardiographic effects of ACE-inhibitors. Acta Cardiol. 45:1990;537-546.
34. Hall A.S., Murray G.D., Ball S.G. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy . Lancet. 349:1997;1493-1497.
35. Heidenreich P.A., McClellan M. Trends in treatment and outcomes for acute myocardial infarction 1975-1995 . Am J Med. 110:2001;165-174.
36. Piepho R. Overview of the angiotensin-converting-enzyme inhibitors. Am J Health-Syst Pharm. 57:2000;S3-S7.
37. Brown N.J., Vaughan D.E. Angiotensin-converting enzyme inhibitors. Circulation. 97:1998;1411-1420.
38. Liang C.S., Gavras H., Black J., Sherman L.G., Hood W.B. Jr. Renin-angiotensin system inhibition in acute myocardial infarction in dogs effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size . Circulation. 66:1982;1249-1255.
39. Pfeffer J.M., Pfeffer M.A., Braunwald E. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation. 75:(1 pt 2):1987;1149-1155.
40. Pfeffer M.A., Hennekens C.H. When a question has an answer rationale for our early termination of the HEART trial . Am J Cardiol. 75:1995;1173-1175.
41. Egger M., Smith G.D., Sterne J.A. Uses and abuses of meta-analysis. Clin Med. 1:2001;478-484.